---
document_datetime: 2023-09-21 21:43:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/hemgenix-epar-all-authorised-presentations_en.pdf
document_name: hemgenix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6945128
conversion_datetime: 2025-12-19 00:53:53.492663
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) Number   | (Invented) name   | Strength       | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size                                                                                                              |
|------------------|-------------------|----------------|---------------------------------------|---------------------------|-----------------------|---------------------------|------------------------------------------------------------------------------------------------------------------------|
| EU/1/22/1715/001 | Hemgenix          | 1 x 10¹³ gc/ml | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 ml                     | Each patient- specific pack contains a sufficient amount of vials to dose each patient with 2 x 10¹³ gc/kg body weight |